Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; The Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois.
Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Jesse Brown VA Medical Center, Chicago, Illinois.
Cell Mol Gastroenterol Hepatol. 2024;18(5):101389. doi: 10.1016/j.jcmgh.2024.101389. Epub 2024 Aug 10.
BACKGROUND & AIMS: The apical-basal polarity of pancreatic acinar cells is essential for maintaining tissue architecture. However, the mechanisms by which polarity proteins regulate acinar pancreas injury and regeneration are poorly understood.
Cerulein-induced pancreatitis was induced in mice with conditional deletion of the polarity protein Par3 in the pancreas. The impact of Par3 loss on pancreas injury and regeneration was assessed by histologic analyses and transcriptional profiling by RNA sequencing. Mice were pretreated with the bromodomain and extraterminal domain (BET) inhibitor JQ1 before cotreatment with cerulein to determine the effect of BET inhibition on pancreas injury and regeneration.
Initially, we show that Par3 is increased in acinar-ductal metaplasia (ADM) lesions present in human and mouse chronic pancreatitis specimens. Although Par3 loss disrupts tight junctions, Par3 is dispensable for pancreatogenesis. However, with aging, Par3 loss results in low-grade inflammation, acinar degeneration, and pancreatic lipomatosis. Par3 loss exacerbates acute pancreatitis-induced injury and chronic pancreatitis-induced acinar cell loss, promotes pancreatic lipomatosis, and prevents regeneration. Par3 loss also results in suppression of chronic pancreatitis-induced ADM and primary ciliogenesis. Notably, targeting BET proteins attenuates chronic pancreatitis-induced loss of primary cilia and promotes ADM in mice lacking pancreatic Par3. Targeting BET proteins also attenuates cerulein-induced acinar cell loss and enhances recovery of acinar cell mass and body weight of mice lacking pancreatic Par3.
Combined, this study demonstrates how Par3 restrains chronic pancreatitis-induced changes in the pancreas and identifies a potential role for BET inhibitors to attenuate pancreas injury and facilitate regeneration.
胰腺腺泡细胞的顶端-基底极性对于维持组织架构至关重要。然而,极性蛋白调节腺泡胰腺损伤和再生的机制仍知之甚少。
通过条件性敲除胰腺中的极性蛋白 Par3 诱导小鼠发生雨蛙肽诱导的胰腺炎。通过组织学分析和 RNA 测序的转录谱评估 Par3 缺失对胰腺损伤和再生的影响。用溴结构域和末端结构域(BET)抑制剂 JQ1 预处理小鼠,然后与雨蛙肽共同处理,以确定 BET 抑制对胰腺损伤和再生的影响。
我们首先表明,Par3 在人类和小鼠慢性胰腺炎标本中存在的腺管化生(ADM)病变中增加。尽管 Par3 缺失破坏了紧密连接,但 Par3 对于胰腺发生是可有可无的。然而,随着年龄的增长,Par3 缺失会导致低度炎症、腺泡变性和胰腺脂肪瘤形成。Par3 缺失会加剧急性胰腺炎诱导的损伤和慢性胰腺炎诱导的腺泡细胞丢失,促进胰腺脂肪瘤形成,并阻止再生。Par3 缺失还导致慢性胰腺炎诱导的 ADM 和初级纤毛发生抑制。值得注意的是,靶向 BET 蛋白可减弱慢性胰腺炎诱导的初级纤毛丢失,并促进缺乏胰腺 Par3 的小鼠的 ADM。靶向 BET 蛋白还可减轻雨蛙肽诱导的腺泡细胞丢失,并增强缺乏胰腺 Par3 的小鼠的腺泡细胞质量和体重恢复。
综上所述,本研究表明 Par3 如何抑制慢性胰腺炎引起的胰腺变化,并确定 BET 抑制剂在减轻胰腺损伤和促进再生方面的潜在作用。